We are live on ! Find out more
JGIA

Jackson Grant Investment Advisers Portfolio holdings

AUM $322M
1-Year Est. Return 20.03%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+20.03%
3 Year Est. Return
+54.33%
5 Year Est. Return
+61.8%
10 Year Est. Return
+185.98%
AUM
$138M
AUM Growth
+$9.43M
Cap. Flow
+$5.59M
Cap. Flow %
4.04%
Top 10 Hldgs %
59.14%
Holding
215
New
31
Increased
120
Reduced
29
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 6.49%
2 Consumer Staples 4.41%
3 Communication Services 2.71%
4 Technology 2.61%
5 Industrials 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
26
TJX Companies
TJX
$178B
$1.06M 0.76%
28,706
-1,698
-6% -$60.5K
XLK icon
27
State Street Technology Select Sector SPDR ETF
XLK
$123B
$846K 0.61%
28,628
-3,224
-10% -$92.9K
AAPL icon
28
Apple
AAPL
$4.57T
$843K 0.61%
21,884
+160
+0.7% +$6.21K
PG icon
29
Procter & Gamble
PG
$339B
$804K 0.58%
8,841
+1,188
+16% +$108K
PEP icon
30
PepsiCo
PEP
$190B
$769K 0.56%
6,902
+47
+0.7% +$5.43K
IWM icon
31
iShares Russell 2000 ETF
IWM
$81.9B
$703K 0.51%
4,743
+271
+6% +$38.1K
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.13T
$687K 0.5%
3,746
+1,271
+51% +$225K
IWC icon
33
iShares Micro-Cap ETF
IWC
$1.5B
$667K 0.48%
7,062
+19
+0.3% +$1.68K
MRK icon
34
Merck
MRK
$318B
$663K 0.48%
10,856
+1,119
+11% +$67.8K
MO icon
35
Altria Group
MO
$114B
$646K 0.47%
10,189
-226
-2% -$15.1K
EMR icon
36
Emerson Electric
EMR
$88.3B
$597K 0.43%
9,498
+8,012
+539% +$483K
ABT icon
37
Abbott
ABT
$187B
$583K 0.42%
10,934
+4,830
+79% +$242K
HDV
38
iShares Core High Dividend ETF
HDV
$14.8B
$580K 0.42%
33,725
+13,390
+66% +$226K
XLU icon
39
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$574K 0.41%
21,634
+316
+1% +$8.48K
CL icon
40
Colgate-Palmolive
CL
$74.4B
$515K 0.37%
7,068
+40
+0.6% +$2.88K
CVX icon
41
Chevron
CVX
$366B
$507K 0.37%
4,313
+1,777
+70% +$194K
BDJ icon
42
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$488K 0.35%
53,821
+604
+1% +$5.37K
WMT icon
43
Walmart Inc
WMT
$890B
$484K 0.35%
18,579
+11,670
+169% +$306K
PFE icon
44
Pfizer
PFE
$153B
$481K 0.35%
14,210
-767
-5% -$24.7K
BXMX
45
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$471K 0.34%
33,699
+448
+1% +$6.21K
CSX icon
46
CSX Corp
CSX
$93.1B
$455K 0.33%
25,164
-1,194
-5% -$20.5K
INTC icon
47
Intel
INTC
$513B
$445K 0.32%
11,682
+3,897
+50% +$139K
BMY icon
48
Bristol-Myers Squibb
BMY
$132B
$420K 0.3%
6,591
+2,686
+69% +$157K
PPG icon
49
PPG Industries
PPG
$26.6B
$411K 0.3%
3,784
+9
+0.2% +$958
VZ icon
50
Verizon
VZ
$196B
$390K 0.28%
7,882
+907
+13% +$42.7K

Similar funds

Jackson Grant Investment Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Jackson Grant Investment Advisers held 215 positions worth $138M, up 7.3% from $129M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Jackson Grant Investment Advisers deployed $5.59M of net new capital in Q3 2017, opening 31 new positions and adding to 120 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $275K.

By sector, the portfolio is most concentrated in Healthcare at 6.5% of assets, up from 5.5% a quarter earlier, followed by Consumer Staples and Communication Services.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $175K trimmed.

  • Jackson Grant Investment Advisers's largest Q3 2017 buy was Berkshire Hathaway Class A: 1 share worth $275K.
  • Jackson Grant Investment Advisers added most to Johnson & Johnson in Q3 2017, an estimated $552K increase.
  • Jackson Grant Investment Advisers's biggest Q3 2017 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $175K.
  • Jackson Grant Investment Advisers fully exited Reynolds American Inc in Q3 2017, selling an estimated $278K.
  • Jackson Grant Investment Advisers's ten largest holdings make up 59% of its $138M portfolio in Q3 2017.
  • Jackson Grant Investment Advisers opened 31 new positions and closed 4 in Q3 2017.
  • Jackson Grant Investment Advisers's portfolio value rose 7.3% quarter-over-quarter to $138M.

Based on Jackson Grant Investment Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.